Despite its smaller population, Switzerland is especially entrepreneurial, having more startups per capita than neighboring countries. Switzerland's proclivity towards innovation has led to the success of its startup ecosystem, having produced more unicorns per capita than other countries in Europe. Known for its liberal economic system and educated populace that is responsive towards innovation, Switzerland has been able to maintain its reputation as an inventive country while remaining competitive in a developing sector; attracting an influx of funds and investments. In this article, we have compiled a comprehensive list of VC funds and angel investors in Switzerland that can assist you in your startup journey.
➡️ Download the full list of VCs and Angel Investors in 100+ countries!

Venture Capitalist Funds in Switzerland
The venture capitalist funds below are actively looking for investments in promising companies throughout various stages and sectors. The stages stated do not limit the possibility of getting funding if your company is at any stage other than what is listed.
Year of Inception: 2018
Stage: Pre Seed, Seed
Focus: Sector Agnostic
Notable Portfolio: Kickbite, Faircado, Aepsy, Peers, Amplo
Year of Inception: 2017
Stage: Pre Seed, Seed
Focus: Technology
Notable Portfolio: Ava, Wingtra, Kollabo, Ava Co
Year of Inception: 2020
Stage: Pre Seed, Seed
Focus: Web 3.0
Notable Portfolio: Grape, Liquity, Pods, Tempus, Myos
Year of Inception: 2020
Stage: Pre Seed, Seed, Series A
Focus: FinTech
Notable Portfolio: Lano, Monite, Pngme, Plend
Year of Inception: 2019
Stage: Pre Seed, Seed, Series A, Series B
Focus: Sector Agnostic
Notable Portfolio: Capskin, Beaconsmind, Growcer, PatchXR
Year of Inception: 2010
Stage: Pre Seed, Seed, Series A, Series B, Series C
Focus: Financial Services
Notable Portfolio: Artivest, Betterment, Bento, Hokodo, EasyHealth
Year of Inception: 2012
Stage: Seed
Focus: FinTech, Internet, Technology
Notable Portfolio: Dimoco, Fumbi, Gemini Interactive, Energyweb
Year of Inception: 2007
Stage: Seed, Series A
Focus: ICT, HealthTech
Notable Portfolio: Carvolution, N26, Razor Group, Lunaphore Technologies
Year of Inception: 2018
Stage: Seed, Series A
Focus: Blockchain
Notable Portfolio: DoxyChain, Forward, Sprinter, Orvium
Year of Inception: 2015
Stage: Seed, Series A
Focus: Fintech & Insurtech, Proptech, Healthtech, E-commerce
Notable Portfolio: Taurus, Yamo, Advanced Oncotherapy, Ava
Year of Inception: 2003
Stage: Seed, Series A
Focus: Biotechnology
Notable Portfolio: Cardior, Precirix, Scenic Biotech, Allecra Therapeutics
Year of Inception: 1993
Stage: Seed, Series A
Focus: Deep Tech, Life Sciences, Digital, High Tech
Notable Portfolio: Core Sensing, Avelo, Invasight, Tubulis
Year of Inception: 2016
Stage: Seed, Series A
Focus: Deep Tech, Fertility, Marketplace, Medtech, Software, Wearables
Notable Portfolio: Keyless, Deliveroo, Creoptix, Ava
Year of Inception: 2018
Stage: Seed, Series A
Focus: Blockchain, Web 3.0
Notable Portfolio: Keyless, Coinfirm, Peddler, Trovio, Delta Exchange
Year of Inception: 2020
Stage: Seed, Series A
Focus: Technology
Notable Portfolio: Cellestia, iQRON
Year of Inception: 2019
Stage: Seed, Series A
Focus: Climate Tech, Sustainable Agri & Food Tech, Clean Energy & Power, Green Transportation & Mobility, Advanced Manufacturing & Resource Efficiency, Carbon Capture, Storage & Utilization
Notable Portfolio: Pipe Predict, Blue Farm, e-mobilio, Flecto
Year of Inception: 2001
Stage: Seed, Series A
Focus: Therapeutics, Drug Development, Biotechnology
Notable Portfolio: Acrivon Therapeutics, BaseLaunch, MinervaX, eyevensys
Momenta Ventures
Year of Inception: 2015
Stage: Seed, Series A, Series B
Focus: Digital Industry, Deep Tech
Notable Portfolio: Decision Engines, Expeto, Eigen Innovations, Conservation Labs
Year of Inception: 2010
Stage: Seed, Series A, Series B
Focus: Science and Technology
Notable Portfolio: Code Intelligence, TheraPixel, Beekeeper, Byrd
Year of Inception: 2012
Stage: Seed, Series A, Series B, Series C
Focus: Technology
Notable Portfolio: Eigen Technologies, Builder.ai, Sennder, Spotify, Revolut
Year of Inception: 2016
Stage: Seed, Series A, Series B, Series C
Focus: Sustainable Food System, Biology, Technology, Agriculture
Notable Portfolio: Alpha Foods, Planted, Mosa Meat, Geltor, Tagger
Year of Inception: 2005
Stage: Seed, Series A, Series B, Series C
Focus: E-Commerce & Consumer Tech, Enterprise Tech, Media & Marketing, FinTech, InsurTech & PropTech, HealthTech
Notable Portfolio: Eureka, Exasol, Lunio, Rebuy, Biogate
Year of Inception: 1996
Stage: Seed, Series A, Series B, Series C
Focus: Technology
Notable Portfolio: Figma, Revolut, Notion, Datadog, Farfetch, Discord
Year of Inception: 2016
Stage: Seed, Series A, Series B, Series C
Focus: Life Sciences
Notable Portfolio: Abivax, Genmab, Levicept, Novocure, Molecular Partners
Year of Inception: 2000
Stage: Seed, Series A, Series B, Series C
Focus: Digital Tech, Industrial Tech
Notable Portfolio: Ledgy, SumUp, DeepL, Raisin, Altoida
Year of Inception: 2003
Stage: Seed, Series A, Series B, Series C
Focus: Technology, Healthcare
Notable Portfolio: Allthings, Blueprint Genetics, Wunderflats, Phenex Pharmaceuticals
Year of Inception: 2001
Stage: Seed, Series A, Series B, Series C
Focus: Technology, Healthcare
Notable Portfolio: Acodis, Inositec, Ledgt, Nexthink, Picterra
Year of Inception: 2016
Stage: Seed, Series A, Series B, Series C
Focus: Deep Tech, Fintech, Health, Mobility, Enterprise Software, Social Media, Cybersecurity
Notable Portfolio: Beekeeper, Lunaphore Technologies, Resistell, Lend
Year of Inception: 2000
Stage: Seed, Series A, Series B, Series C
Focus: HealthTech, Medical Devices, Diagnostics, Digital Health
Notable Portfolio: Relievant Medystems, Miach Orthopaedics, Virtual Incision, Kenbi
Year of Inception: 2001
Stage: Seed, Series A, Series B, Series C
Focus: Healthcare
Notable Portfolio: Acrivon Therapeutics, Egenesis, Mineralys, Neurelis
Year of Inception: 2018
Stage: Seed, Series A, Series B, Series C
Focus: B2B, HealthTech, Medical Devices, Diagnostics, Digital Health
Notable Portfolio: Neurocare, InterAx, Gedea Biotech, Neotiv
Year of Inception: 2015
Stage: Seed, Series A, Series B, Series C
Focus: B2B, Software, Cyber Security, Big Data, Artificial Intelligence, Health Tech
Notable Portfolio: Via, Techsee, Nozomi Networks, Tribe Dynamics
Year of Inception: 1998
Stage: Series A
Focus: Biotechnology, Cancer Therapeutics, Oncology Therapeutics
Notable Portfolio: Arvinas, Turning Point Therapeutics, Blueprint Medicines, EQ Rx
Year of Inception: 2010
Stage: Series A
Focus: Circular Production & Consumption, Clean Energy, Sustainable Food
Notable Portfolio: Amandera, Beyond Impact, Farmstand, Ynsect
Year of Inception: 2016
Stage: Series A, Series B
Focus: Sector Agnostic
Notable Portfolio: CNC24, Calingo, Sinpex, RightNow, Xorlab
Year of Inception: 1991
Stage: Series A, Series B, Series C
Focus: Life Sciences, Therapeutics, Medical Devices, Diagnostics, Digital Health, Biotechnology
Notable Portfolio: Invendo Medical, STipe Therapeutics, MTM Laboratories, Amboss
Year of Inception: 2018
Stage: Series A, Series B, Series C
Focus: Artificial Intelligence, Machine Learning, Big Data, IoT, Automation, Immersive Technologies
Notable Portfolio: Tinamu Labs, Imverse, Astrocast, Smeetz
Year of Inception: 2000
Stage: Series A, Series B, Series C
Focus: Technology, Advanced Materials, Agriculture, Energy, Industrial IT, Water
Notable Portfolio: Aganova, Nanograf, Evergreen Solar, Optimatics, Energya Wind Technologies
Year of Inception: 1996
Stage: Seed, Series A, Series B, Series C
Focus: Healthcare, Biotechnology
Notable Portfolio: Fore, GentiBio, Immunitas Therapeutics, Oculis
Year of Inception: 2007
Stage: Seed, Series A, Series B, Series C
Focus: Technology
Notable Portfolio: Cato Networks, Billogram, SecuriThings, XFarm Technologies
Year of Inception: 2009
Stage: Seed, Series A, Series B, Series C
Focus: Agriculture & Food
Notable Portfolio: Sound Agriculture, Bionogsys, Agrofy, BlueNalu, MycoTechnology
Year of Inception: 2002
Stage: Series A, Series B, Series C
Focus: Life Sciences, Pharmaceuticals, Diagnostics, Digital Health
Notable Portfolio: Blueprint Medicines, Corvus, Enliven Therapeutics, Lumos Pharma
Angel Investors in Switzerland
The Angel investors listed below are part of an Angel community located throughout Switzerland. They may act as an individual or as a syndicate to fund projects of their preference, so these networks are the best opportunity for you to find a potential Angel with an aligned vision and interests.
Stage: Seed
Focus: Sector Agnostic
Notable Portfolio: -
Stage: Seed, Series A
Focus: Sector Agnostic
Notable Portfolio: Piavita, Goodwall, Avionic, Alao
Stage: Seed, Series A
Focus: Sector Agnostic
Notable Portfolio: -
Stage: Seed, Series A
Focus: Sector Agnostic
Notable Portfolio: Creoptix, Hylomorph, ActLight, Typewise, BC Platforms
Stage: Seed, Series A
Focus: Technology
Notable Portfolio: Adjoint, Advanon, Voltiris, Carbon Delta, Codecheck
Stage: Seed, Series A
Focus: e-Commerce, High Tech, MedTech, Automotive
Notable Portfolio: Clevver, Myos, Libify, Ubiq, Yeay
Stage: Seed, Series A
Focus: Healthcare
Notable Portfolio: Cellestia, Artidis, Elthera
Closing Thoughts on VCs and Angel Investors in Switzerland
Switzerland's startup environment is analogous to a large laboratory. Thanks to diverse high-tech clusters in the technological area, the country has enabled collaboration with industry leaders, innovation drivers, and capital providers. Tight links between business, academics, and venture funds are particularly beneficial for translating research, testing new applications, and advancing inventions. As such, the country is particularly ideal for technological startups looking to access capital to advance, commercialize, and grow their research into sustainable businesses.
Find VCs and Angel Investors in Europe:
Frequently Asked Questions on VCs and Angel Investors in Switzerland
How is Switzerland's venture capital and startup ecosystem structured?
Switzerland's venture capital ecosystem is highly sophisticated, centered in key innovation hubs like Zürich, Basel, and Lausanne. Major players include the Swiss Private Equity & Corporate Finance Association (SECA), Swiss ICT Investor Club (SICTIC), and established VC firms like Redalpine and btov Partners. The ecosystem leverages Switzerland's strong financial sector, research institutions, and innovation parks. Government support comes through Innosuisse and cantonal economic development agencies. The Swiss Entrepreneurs Foundation and Venture Kick provide additional startup funding infrastructure.
What funding options are available for Swiss startups?
Swiss startups can access multiple funding channels: seed funding through StartAngels Network (100,000-500,000 CHF), business angel investments via SICTIC and BAS (500,000-2M CHF), and early-stage VC funding (2M-10M CHF). The Swiss Entrepreneurs Fund provides scale-up capital. Additional support comes through CTI Invest and regional innovation agencies. Later-stage funding often involves international VC partnerships, particularly from German and US investors. Corporate venture arms of major Swiss companies, especially in pharma and finance, provide strategic investment opportunities.
Which sectors attract the most investment from Swiss VCs and angels?
Swiss investors show strong preference for sectors aligned with national strengths: biotech (particularly in Basel), medtech, fintech (especially in Zug's Crypto Valley), and deep tech. There's significant interest in cleantech and sustainable technology solutions. Life sciences and pharmaceutical startups attract substantial investment, leveraging Switzerland's strong research base. Emerging areas include blockchain technology, AI/ML applications, and precision engineering solutions. Enterprise software and B2B platforms targeting regulated industries are also popular.
What criteria do Swiss investors use to evaluate startups?
Swiss VCs prioritize teams with strong technical expertise and international market potential. Key requirements include clear intellectual property protection, demonstrated product-market fit, and scalable business models. Most investors expect startups to have Swiss company registration and connections to local research institutions or industry clusters. Understanding of both Swiss and EU markets is crucial. ESG considerations and sustainability metrics are increasingly important, particularly for impact-focused funds.
How can entrepreneurs connect with Swiss investors?
Key networking channels include Swiss Startup Days, TOP 100 Swiss Startup Award events, and Venture Lab programs. Technology parks like Switzerland Innovation Park and EPFL Innovation Park provide direct access to investor networks. Accelerators like MassChallenge Switzerland and Kickstart facilitate investor connections. Industry-specific platforms like Swiss Fintech Innovations offer targeted networking opportunities. Many Swiss VCs maintain strong ties with German, French, and US investors, offering potential for international funding rounds.
Comments